Related by context. All words. (Click for frequent words.) 85 AKIP ™ 81 AKIP TM 80 ArQule Kinase Inhibitor 71 AKIP 70 novel peptide 69 factor receptor FGFR 69 DiLA2 68 FOLOTYN ® 68 product platforms AZX# 68 optical biosensors 68 novel peptides 68 histone deacetylase HDAC 68 rxRNA 67 MDRNA proprietary 67 novel anti infective 67 Nasdaq LXRX biopharmaceutical 67 HuCAL GOLD R 67 Adnectin 67 Kosan dependence 67 ALN PCS 67 oncolytic virus therapies 67 Locked Nucleic Acid 67 RECOTHROM R 67 small molecule agonists 67 Selective Electrochemical Tumor Ablation 66 novel kinase inhibitors 66 targeted radiotherapeutic 66 proprietary PEGylation 66 Ligand proprietary 66 isoform selective 66 novel RNAi therapeutics 66 candidates Azedra TM 66 OTCBB PYTO 66 Solazed TM 66 pralatrexate injection folate analogue 66 platform HDL Mimetic 66 humanized anti 66 P#X# antagonist 66 humanized monoclonal 66 developing calcitonin 66 TRANSDUR ™ 65 FGFR 65 AAG geldanamycin analog 65 introduced NEUGENE 65 Locked Nucleic Acid LNA 65 stable nucleic acid 65 LentiVector technology 65 lipid nanoparticle 65 Micromet proprietary BiTE 65 adrenergic regulation 65 Alfacell proprietary ribonuclease 65 Fc fusion protein 65 LNP formulations 65 Epothilones 65 novel VDA molecule 65 Homspera TM 65 mda 7 65 delivery polymer matrix 65 humanized monoclonal antibodies 65 NEUGENE R 65 nucleoside tide 65 therapeutic monoclonal antibody 65 immunotherapeutics 65 HCV protease inhibitor 65 SNALP technology 65 Factor Receptor 65 Immunotherapeutic 65 Reports Preclinical Data 65 biologic therapeutics 65 fatty acid amide hydrolase 65 therapeutic monoclonal antibodies 65 G Protein Coupled 64 Nanobody 64 JAK2 Inhibitor 64 Receptors GPCRs 64 POTELLIGENT ® 64 Presents Preclinical Data 64 PDE4 inhibitor 64 metabolite identification 64 purinergic receptors P#X# 64 investigational humanized monoclonal antibody 64 DXL TM 64 novel immunotherapies 64 telomerase inhibitor drug 64 kidney urologic 64 delipidation 64 BioFocus DPI Galapagos 64 Initiates Clinical Trial 64 NuMimetic TM 64 London AiM GLPG 64 pan HDAC inhibitor 64 Avian Transgenic Technology 64 ABL inhibitor 64 anticancer therapeutics 64 SMaRT ™ 64 orally bioavailable mimics 64 A3 adenosine receptor 64 Personalized Immunotherapy 64 Akebia Therapeutics 64 IAP inhibitors 64 vaccine GRNVAC1 64 HuCAL 64 Initiates Phase II 64 pharmacological chaperone 64 recombinant vaccines 64 2 inhibitor CYT# 64 developing TB4 64 HuCAL GOLD 64 ZEVALIN ® 64 CYT# potent vascular disrupting 64 DOS# 64 HuCAL PLATINUM ® CysDisplay 64 taxane derivative 64 Fibroblast Growth Factor Receptor 64 mRNA antagonists 64 MKC# MKC# PP 63 patented Bioral 63 HuLuc# 63 HDL Therapy 63 Aurora kinase inhibitor 63 OTCBB HXBM developer 63 MP4 molecule 63 POTELLIGENT R 63 Peptidomics 63 skeletal sarcomere activators 63 novel immunomodulatory 63 proprietary BiTE ® 63 HuCAL R 63 DsiRNA 63 IMiDs R 63 HCV polymerase 63 Delipidation 63 Nanobody R 63 cellular immunotherapy 63 novel L DOS# 63 Telik logo TELINTRA 63 Zalypsis 63 oral ghrelin agonist 63 rxRNA compounds 63 novel therapeutic antibodies 63 SynCon 63 Completes Patient Enrollment 63 DECIPHER R 63 ATRA IV 63 Small Molecule 63 R#/MEM 63 HuMax TAC 63 PI3K/Akt pathway inhibitor 63 SinuNase ™ 63 selective inhibition 63 gastro intestinal inflammation 63 adecatumumab MT# 63 BCR ABL inhibitors 63 selective kinase inhibitor 63 phage display technology 63 oral proteasome inhibitor 63 ALN TTR 63 HDL Mimetic Peptide 63 Aganocide ® 63 accumulate preferentially 63 Adenosine Therapeutics 63 BiTE R 63 rusalatide acetate 63 Inc. AMEX YMI 63 Biosensor System 63 ESPRIT therapy 63 telomerase therapeutic 63 targeting CD# 63 Alnylam #x# 63 vivo fluorescence imaging 63 protein tyrosine phosphatase 1B 63 LHRH antagonists 63 Potelligent Technology 63 PORxin TM 63 OTCBB QTXB 63 MT#/MEDI-# 63 PEG SN# 63 predictive toxicology 63 Nanobody ® 63 Announces Poster Presentations 63 ALN TTR# 63 HCV NS3 protease 63 OTCQB CTIX 63 CysDisplay R 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 derivatives Radilex TM 63 investigational pan BCR 63 Cyclosert 63 www.ucb group.com 63 Alzheimer disease cognitive impairment 63 candidate CRLX# 63 peptide peptide mimetic 63 commercializing anti infective 63 dSLIM 63 MKC# MT 63 oncolytic viruses 63 DNA methylation biomarkers 63 EGIR 63 ZFP Therapeutics 63 personalized cellular immunotherapy 63 potently inhibit 63 small molecule defensin 63 Antibody Drug Conjugate 63 molecular imaging radiopharmaceuticals 63 Provectus Pharmaceuticals specializes 63 Xcytrin R 63 peptidic compound 63 EndoTAG TM 63 Therapeutic Competitors Companies 62 systemic RNAi 62 GVAX ® 62 MOVIPREP R 62 virosome 62 tiapamil 62 recombinant antibodies 62 Presents Preclinical 62 Zemiva TM 62 Aptamer 62 Fleximer 62 HepDirect R 62 Protein Kinase C 62 anti infective treatments 62 selective orally bioavailable 62 anionic backbone 62 DiLA2 Platform 62 liposomal delivery 62 NurOwn 62 SNALP 62 Anticalins R 62 mertansine 62 lipid particles SNALP 62 orally administered inhibitor 62 Transfection Reagent 62 transfection reagents 62 next generation URAT1 62 NTDDS 62 PROfusion 62 XL# anticancer compounds 62 Intravenous Human 62 targeted antifolate 62 liposomal formulation 62 Systemic Delivery 62 non nucleoside inhibitor 62 Eg5 kinesin spindle 62 Captisol ® 62 biologically validated targets 62 ENMD # 62 THR beta agonist 62 Initiates Enrollment 62 Hsp# Inhibitor 62 Pentad TM 62 novel antibody therapeutics 62 Monoclonal Antibody 62 peptibody 62 NovaBay Aganocide compounds 62 TRANSDUR ® 62 5 HT6 receptor 62 Technology LVT 62 genomic proteomic 62 proprietary polysaccharide 62 AMEX REX 62 NS5b 62 HuMax 62 VentiRx Pharmaceuticals 62 Panzem R 62 vitro ADME 62 MEK inhibitor 62 Tr DNA 62 multi kinase inhibitor 62 immunotoxins 62 Epigenomics proprietary 62 Awarded Qualifying Therapeutic 62 recombinant biopharmaceutical 62 engineered RAP peptides 62 systemic RNAi therapeutic 62 Phase #b/#a clinical 62 antagomirs 62 VitiGam 62 proteasome inhibitor 62 Azedra ™ 62 anti CD# antibodies 62 Novosom 62 Cyclosert TM 62 Neurogen Corporation 62 HER1 62 highly selective inhibitor 62 Idera Pharmaceuticals 62 MediVas 62 monoclonal antibody mAb 62 PNP inhibitor 62 evaluating satraplatin 62 XL# XL# 62 ThermoDox ® clinical 62 SCIB1 62 toxicogenomics 62 CobaCyte 62 Initiate Clinical Trial 62 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 62 RNAi Consortium 62 patented NanoStat ™ 62 Pertuzumab 62 PROLOR Biotech Inc. 62 external counterpulsation systems 62 apricitabine ATC 62 platinum chemotherapeutic 62 deCODE chemistry 62 Epidermal Growth Factor Receptor 62 reversible inhibitor 62 targeted anticancer therapies 62 liposome encapsulated 62 RNAi therapeutic platform 62 BHT DNA 62 AtuRNAi 62 NS#/#A protease 62 trastuzumab DM1 T DM1 62 IMiDs ® compound 62 Therapeutic Vaccine 62 oral salmon calcitonin 62 Nasdaq RDEA 62 Viprovex R 62 lexidronam injection 62 Elagolix 62 protein kinase inhibitor 62 ZFP TFs 62 Nasdaq IDIX biopharmaceutical 62 ARRY # 62 Liprotamase 62 SIRT1 activators 62 Valortim TM 62 Alnylam Biotherapeutics 62 oncology therapeutics 62 IgG1 monoclonal antibody 62 siRNA binds 62 transrenal DNA 62 silicon carbide SiC gallium 62 Achieves Primary Endpoint 62 proprietary bioresorbable polymer 62 biased ligand 61 Panzem ® 61 Tissue Repair Company 61 DURECT proprietary 61 rxRNA ™ compounds 61 miRagen 61 Board LWLG technology 61 immunoregulation 61 RONDEL ™ 61 Factor VIIa 61 JAK2 inhibitor 61 molecular biomarkers 61 Curaxin 61 Electroporation 61 nitric oxide donating prostaglandin 61 M2 subunit 61 PROSTASCINT R 61 NYSE Amex PBTH 61 cMET 61 proprietary biomaterials 61 tubulin inhibitor 61 PDE# inhibitors 61 MPH AMEX 61 Tß4 61 Prestara TM 61 molecular chaperone regulation 61 anti CD# monoclonal 61 XmAb TM 61 2 methoxyestradiol 61 coronary stent merged 61 single stranded oligonucleotides 61 XmAb ™ 61 Ad5FGF 4 61 generation nucleoside analog 61 transcutaneous immunization TCI 61 SMARTICLES ® 61 humanized antibody 61 acetylcholinesterase AChE 61 DiLA 2 61 protein biomarker discovery 61 ASG 5ME 61 small molecule modulators 61 exon skipping 61 TSX VENTURE GAP 61 Initiates Clinical 61 siRNA compounds 61 non nucleoside HCV 61 Nasdaq IDRA today 61 TRAIL receptor antibodies 61 MetaDrug TM 61 EP #R 61 NASDAQ ABII 61 MelaFind R 61 Inc. Nasdaq INFI 61 proprietary LNA 61 proprietary BiTE R 61 mGluR2 NAM 61 Viprovex TM 61 COX Inhibiting Nitric Oxide 61 PRNewswire FirstCall Neurogen 61 Novel Oral 61 Nasdaq SGMO 61 romazarit 61 TRACON Pharmaceuticals 61 Dyax phage display 61 cancer immunotherapies 61 programs visit http:/www.bionovo.com 61 prodrugs 61 CD# CEA 61 tkRNAi 61 HIV AIDS neuropathic pain 61 DNA RNA Medicines 61 Aganocide TM 61 antisense inhibitors 61 detection reagents 61 CB2 selective 61 drug conjugate 61 Nasdaq PARD biopharmaceutical 61 Protexia ® 61 TGR5 61 allosteric modulation 61 Nasdaq PARD 61 siRNA therapeutic 61 oral prodrug 61 RenaZorb TM 61 Kinase Inhibitor 61 CD# monoclonal antibody 61 MorphoSys proprietary 61 HuCAL antibodies 61 RNAi therapeutic targeting 61 AdVac ® 61 RNA interference RNAi therapeutics 61 Inc. NASDAQ IDMI 61 visit http:/www.mannkindcorp.com 61 Squalamine 61 Regado 61 microtubule inhibitor 61 RNAi Therapeutic 61 ddRNAi 61 topically applied SEPA 61 Genotyping Test 61 Intravenous CP 61 InterfeRx TM 61 selective immunoproteasome inhibitor 61 HuCAL antibody 61 Nasdaq HALO biopharmaceutical 61 Nasdaq RXII 61 Brussels THR 61 molecular imaging radiopharmaceutical 61 PORxin TM platforms 61 monoclonal antibody therapeutics 61 P#X# 61 Cetrorelix 61 generation URAT1 inhibitor 61 Nektar pulmonary 61 5 HT6 61 Vaxfectin 61 Prednisporin 61 myelofibrosis polycythemia vera 61 Novavax VLP vaccine 61 tests miRview TM 61 therapeutic peptide 61 zinc finger nuclease 61 Novel Mechanism 61 synthetic cannabinoid compounds 61 proprietary Biochronomer 61 Daclizumab 61 HTS assay 61 Protein Expression 61 RECOTHROM ® 61 Inc. Nasdaq IMGN 61 Nasdaq IDRA 61 Activity Assay 61 investigational therapies 61 agonist compounds 61 NEUGENE 61 histone deacetylase HDAC inhibitor 61 proven DuraSite ® 61 antibody humanization 61 Alligator Bioscience AB 61 AMPK activators 61 diseases fat malabsorption 61 miRNA therapeutics 61 HCV protease inhibitors 61 theranostic 61 Maxy G# 61 OTCBB PWRM.OB 61 docetaxel Taxotere R 61 TIMERx 61 endosomal release 61 Endotis 61 attach auristatin 61 ActivX 61 metabolite profiling 61 CCX# 61 TKB# 61 Drug Candidate 61 TLR9 agonists 61 epothilones 61 OTC Bulletin Board LWLG 61 pentadentate logo R 61 Tesetaxel 60 Bioral ® 60 Ibis T# TM 60 HSP# inhibitor 60 intranasal vaccines derived 60 small molecule thrombopoietin 60 encapsulates siRNAs 60 developing Bicifadine serotonin 60 Biomarker Study 60 sirtuin therapeutics 60 Genedata Expressionist ® 60 neuronal nicotinic receptor NNR 60 CobOral oral drug 60 taste modulators 60 Files IND 60 NeutroPhase TM 60 glucagon receptor 60 HepeX B TM 60 FORMA Therapeutics 60 XmAb 60 Agonist MABA program 60 include PLX IBD 60 leukotriene pathway 60 mitogen activated ERK kinase 60 virus AAV 60 telomerase inhibitor 60 RNA antagonist 60 novel histone deacetylase 60 Dicer Substrate Technology 60 SERMs 60 utilizes InSite Vision 60 Genisphere 60 Tumour Vascular Disrupting Agent 60 tests miRview ™ 60 Neurome 60 nicotinic alpha 7 60 MetaBase TM represents 60 evaluating tivozanib 60 Infinium assay 60 RapMAT ® 60 CompoZr 60 HTRF 60 Present Preclinical Data 60 S#P# 60 HCV NS5B polymerase 60 Pharma Merck Serono 60 NASDAQ ALTH biopharmaceutical 60 Trofex TM 60 About Positron Positron 60 adenovector 60 MVA BN R 60 GeneICE 60 microRNA therapeutics 60 molecular chaperone amplification 60 CEQ# 60 Alvine Pharmaceuticals 60 NovaDel oral spray 60 Ibis T# 60 Elvitegravir 60 Nasdaq XTLB 60 Compugen NASDAQ CGEN 60 Hedgehog pathway inhibitor 60 Myolimus 60 chimeric monoclonal antibody 60 BXT # 60 agonistic human 60 JAK3 60 mediate RNAi 60 vapreotide acetate 60 proprietary capillary aerosolization 60 Hybridon 60 HyACT 60 NASDAQ INGN 60 Prodarsan R 60 Agios Pharmaceuticals 60 Nasdaq IMGN 60 Sangamo ZFP technology 60 PSMA ADC 60 Anticalin R 60 Nexavar ® 60 rHuPH# enzyme 60 selective inhibitors 60 EnVivo Pharmaceuticals 60 JAK3 inhibitor 60 GMX# 60 subsidiaries InnerCool Therapies 60 anti CD3 monoclonal 60 Blinatumomab 60 GRNVAC1 60 Zemiva TM Trofex TM 60 TÎ ² 4 60 lead molecular radiotherapeutic 60 orally bioavailable 60 lipid nanoparticles 60 Veronate R 60 Anti Tumor 60 OTCBB CHKT 60 Epeius Biotechnologies Corporation 60 methylation markers 60 INS# [001] 60 Atripla combines 60 Corgentin 60 samarium Sm 60 targeting Inflammatory Bowel 60 staphylococcal vaccines 60 Litx 60 DNAi 60 ALN VSP 60 DG# compounds targeting 60 candidate XP# 60 Trastuzumab DM1 60 Hypoxia Inducible Factor 60 histone deacetylase inhibitor 60 ZaBeCor 60 enhance ApoA 60 proprietary transdermal 60 ALN HPN 60 Solazed 60 Preclinical studies suggest 60 polymerase inhibitors 60 including thyroiditis RA 60 Euronext Amsterdam GLPGA 60 staphylococcal vaccine 60 Nutra Pharma wholly owned 60 sarcoma melanoma 60 treat refractory angina 60 recurrent metastatic ovarian cancer 60 Thiarabine 60 novel synthetic peptide 60 using ImmunoGen TAP 60 ZFP TF 60 Bavarian Nordic patented 60 throughput RNAi 60 siRNA delivery 60 Ii protein 60 Helinx technology 60 ERYtech 60 Inc. Nasdaq ALNY 60 Kwanika copper gold 60 nucleoside tide analogs 60 ghrelin antagonist 60 RELOVAIR ™ 60 Cobalamin TM mediated 60 PDX pralatrexate 60 intracellular signaling pathways 60 selective estrogen receptor modulator 60 Restoraderm 60 small molecule inhibitors 60 Azedra 60 Panzem 60 products MKC# PP 60 Arcelis ™ 60 TELINTRA R 60 Nasdaq PPHM 60 Chemokine Receptor 60 Curaxin CBLC# 60 Marqibo TM 60 Western Blotting 60 Nasdaq CGEN 60 vivo validation 60 Tiuxetan 60 metabolomics driven 60 unique PER.C6 60 Tyrosine Kinase Inhibitor 60 tyrosine kinase inhibitor TKI 60 eligen R technology 60 Rigel R# 60 biomodulator 60 biomarker identification 60 Protein Interactions 60 blood serum biomarkers 60 ELADUR ™ 60 CHEMSAS R 60 small molecule activators 60 EHT AGN 60 drug conjugate ADC 60 Ostabolin C TM 60 pathophysiological effects 60 Anticalin ® 60 Liposomal 60 5 HT2A inverse 60 AN# novel 60 HDAC Inhibitor 60 beta secretase inhibitors 60 MassARRAY ® 60 oral Janus kinase 60 TRX1 60 KL4 Surfactant 60 HepDirect 60 polyclonal antibody 60 AFREZZA TM 60 ospemifene 60 Glufosfamide 60 novel emulsion formulation 60 Mersana Therapeutics 60 RNAi Therapeutics 60 JAK2 kinase 60 biochemical profiling 60 AKT inhibitor 60 Kinase Inhibitors 60 AB OMXS BINV 60 recombinant subunit vaccine 60 genomics transcriptomics 60 UsiRNAs 60 Transfluor 60 synthetic peptides 60 candidate NGX 60 HepDirect prodrug 60 CCR9 antagonist 60 myasthenia gravis Huntington 60 developing Zerenex TM 60 metabonomics 60 PLK1 SNALP 60 hyaluronidase enzyme 60 proprietary MSCRAMM protein 59 Helix BioMedix Inc. 59 apoptosis inducers 59 AEG# 59 Ascent Therapeutics 59 rxRNA TM compounds 59 Crofelemer budesonide foam 59 immune modulating 59 Medarex UltiMAb R 59 prostone 59 flavors flavor enhancers 59 PHX# 59 oral taxane 59 Molecular Cancer 59 JAK1 59 Alnylam RNAi 59 genomic biomarker 59 inhibitor PPI 59 Histone Deacetylase 59 Aganocide 59 immunotherapeutic approaches 59 CDK cyclin dependent 59 NASDAQ SNTA 59 anti amnesic 59 siRNA therapeutics 59 PER.C6 r 59 Fleximer R 59 BACcelr8r TM 59 interferon alpha IFN 59 Nasdaq CYTR biopharmaceutical 59 anticoagulant reversing agent 59 non porcine pancreatic 59 HCV polymerase inhibitors 59 NB S# strontium malonate 59 IMA# 59 FoldRx Pharmaceuticals Inc. 59 therapeutic mAbs 59 IMiDs ® 59 NGFN 59 ProNAi 59 SpliceArray 59 Preclinical Study 59 New Chemical Entities 59 Aplidin R 59 tkRNAi technology 59 Begins Dosing 59 oral transdermal 59 MAXY G# 59 RNA antagonists 59 synthetic retinoid 59 recombinant fusion 59 HSP# inhibitors 59 Alnylam Nasdaq ALNY 59 acetonide FA 59 SmartChip TM Real 59 Company Nasdaq RGDX 59 Panzem R NCD 59 Eligen ® Technology 59 peptide conjugated 59 monoclonal antibody MAb 59 cyclodextrin containing polymers 59 immunotherapeutic agent 59 proprietary MSCRAMM ® 59 Sphingomab 59 Abstract Accepted 59 patented NanoStat TM 59 Micromet BiTE 59 Anticalin 59 Guanilib 59 TLK# 59 hormone agonist 59 investigational monoclonal antibody 59 CCR5 mAb 59 Angiocept 59 Voreloxin 59 MCSP respectively 59 HGS ETR1 mapatumumab 59 novel orally bioavailable 59 catalytic antioxidant compounds 59 AVEO integrates proprietary 59 ALTROPANE R 59 Pervasis 59 Oracea TM 59 Romidepsin 59 OTCBB IMNR 59 Xencor XmAb 59 engineered proteases 59 StromaCel Inc. 59 IAP inhibitor 59 intranasal formulation 59 candidate deforolimus 59 Aurora Kinase 59 NanoTab 59 including Cobalamin TM 59 oncolytic 59 Oligonucleotide 59 selective androgen receptor modulators 59 Bafetinib 59 Quark Biotech Inc. 59 Pentraxin 2 59 proprietary BiTE antibody 59 Myocet 59 SELDI 59 QUADRAMET R 59 immunomodulatory properties 59 small molecule chemopotentiator 59 Bioral Amphotericin B. 59 Therapeutic antibodies 59 POTELLIGENT R Technology 59 PRNewswire FirstCall Nastech Pharmaceutical 59 darinaparsin ZIO 59 Radiation Therapy SIRT 59 Symphony tCGM 59 PEGylated interferon 59 Innovive Pharmaceuticals 59 PER.C6 ® production 59 Vegenics 59 ARE NOT INDICATIVE OF 59 ZFP Therapeutic TM 59 TLR9 agonist 59 vinca alkaloid 59 ZFN TM 59 adenosine A2A 59 COMPLEGENT TM Technologies 59 Ultrafast Insulin 59 electro optic polymer 59 recombinant adeno associated 59 potent inhibitors 59 Antigenics QS 59 plasmid DNA vaccine 59 eTag assays 59 vidofludimus 59 QuantRx Biomedical Corporation 59 hyperphosphorylation 59 NASDAQ CGEN announced 59 anticancer compound 59 RNAi gene silencing 59 immune modulators 59 Deforolimus 59 Xanafide 59 Successfully Completes Phase 59 Morpholino 59 prostanoid 59 cleavable linker 59 multiplexed assays 59 KL4 surfactant 59 Archexin 59 ProMIS TM 59 reverse vaccinology 59 PDE# 59 AtuPLEX 59 Pruvel ™ 59 antisense oligonucleotides 59 biomarkers predictive 59 Frankfurt XMP 59 Thrombin topical Recombinant 59 motexafin gadolinium Injection 59 KAI Pharmaceuticals 59 enzymes immunodiagnostics 59 Receptos 59 antibody MT# 59 Metaphore 59 doxorubicin Transdrug R 59 alpha folate receptor 59 PEGylation 59 siRNA conjugates 59 Genasense ® oblimersen 59 TOCOSOL 59 selective antagonist 59 ALN HTT 59 Nasdaq OMER 59 Vicriviroc 59 oral probiotic 59 multimodality imaging 59 Photodynamic therapy PDT 59 AE# vaccine 59 NRGN 59 chemically modified siRNA 59 YONDELIS 59 Lexicon Genetics Incorporated 59 Inc. www.chemaphor.com uses 59 Aeolus Pharmaceuticals Announces 59 DepoVax TM 59 inhaled formulation 59 small molecule tyrosine 59 Trodusquemine MSI 59 Cardiomyocytes 59 potent cytotoxic 59 cardiac muscle contractility 59 mitotic kinesins 59 4SC AG ISIN DE# 59 vaccines oncolytic virus 59 WEB OF SCIENCE 59 poly ethylene glycol PEG 59 acid phosphatase PAP 59 inhibit KSP 59 developing biomedical countermeasures 59 Smac mimetics 59 Aurora kinase 59 polymer conjugate technology 59 SENOMYX 59 TransVax ™ 59 hypoxia activated prodrug 59 Memory MRAM 59 Mg Usa 59 leading lipid nanoparticle 59 erlotinib Tarceva R 59 CORT # 59 Metallophile ™ Technology 59 RainStorm 59 Vaxfectin adjuvant 59 Insegia 59 immune modulatory 59 delta isoform 59 novel antiviral therapeutics 59 PDE7 59 Bioral 59 synthetic peptide 59 HyperAcute 59 cathepsin K inhibitor 59 SGLT Inhibitors 59 immatics 59 peptidomimetic 59 GeoVax AIDS vaccine 59 Stapled Peptide 59 #/#/# Cytokinetics Incorporated 59 Onalta ™ 59 PI3 Kinase 59 HuCNS SC ® 59 Ligands 59 TSX VIR 59 SARMs 59 acyclovir Lauriad R 59 NPC 1C 59 Enhanze TM Technology 59 Receives Orphan Drug Designation 59 VeraTag 59 canola proteins Puratein 59 Fraunhofer CMB 59 TM Aganocide 59 GelSite polymer 59 lipid particles 59 Cancer Vaccines 59 buccal delivery 59 poly ADP ribose polymerase 59 product Fentanyl TAIFUN 59 initiated Phase 1b 59 Government Qualifying Therapeutic 59 OTCBB CHKT biotechnology 59 Etubics 59 Intracellular Receptors IRs 59 low toxicity bioscience 59 proprietary Dicer Substrate Technology 59 NS4A 59 siRNAs targeting 59 Optical Biopsy System 59 MolecularBreeding 59 peroxisome proliferator activated 59 sapacitabine CYC# 59 anticancer compounds 59 cHTS 59 PKC# 59 HDL Selective Delipidation 59 MSCRAMM ® 59 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 59 Cerashield ™ 59 Circ Pharma 59 ACTCellerate 59 Nasdaq ENZN 59 Antisense 59 TSX CTI 59 bioactive compound 59 NYSE Amex PTN 59 LPM TM 59 AdVac R 59 paclitaxel Taxol ® 59 molecular chaperone technology 59 polymerase inhibitor 59 Enhanze 59 Kiadis 59 3 kinase PI3K 59 Nasdaq MNKD focused 59 JAK inhibitors 59 immunotherapeutic vaccine 59 thetreatment 59 personalized dendritic 59 RiVax TM